Renal impairment with sitagliptin: is there a need for active monitoring of potential renal toxicity?

Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome

(2010) David S Tofovic et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Exenatide and renal failure

(2010) J. C. Ferrer-Garcia et al.   DIABETIC MEDICINE

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

(2008) J. C. N. Chan et al.   DIABETES OBESITY & METABOLISM

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use

(2008) D. P. Kao et al.   DIABETIC MEDICINE

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?

(2008) B. J. Boucher   DIABETIC MEDICINE

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE